Investigating inflammation markers in age-related vision loss
Biomarkers of Systemic Inflammation in Intermediate Age-Related Macular Degeneration
This study is looking at how inflammation in the body might influence the worsening of intermediate age-related macular degeneration (iAMD), a condition that can cause serious vision problems for older adults, and it aims to find specific markers in blood samples that could help predict the risk of more severe vision loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10828736 on NIH RePORTER |
What this research studies
This research focuses on understanding how systemic inflammation affects the progression of intermediate age-related macular degeneration (iAMD), a condition that can lead to severe vision loss in older adults. By analyzing blood samples from patients with iAMD, the study aims to identify specific inflammatory markers that may indicate the risk of developing advanced forms of the disease. The research utilizes a registry of patients in Colorado and employs advanced imaging techniques to correlate inflammation levels with retinal changes. This approach could help in developing targeted therapies to slow down or prevent vision loss.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults diagnosed with intermediate age-related macular degeneration.
Not a fit: Patients with advanced age-related macular degeneration or those without any form of macular degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing the progression of age-related macular degeneration, potentially preserving vision for many patients.
How similar studies have performed: Previous studies have shown promising results in linking inflammation to age-related macular degeneration, suggesting that this approach could yield valuable insights.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Lynch, Anne M. — University of Colorado Denver
- Study coordinator: Lynch, Anne M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.